Jennifer Guerriero, Dana-Farber Cancer Institute (IMAGE)
Caption
Dr. Guerriero led a new study that shows a compound able to reverse the allegiance of innate immune system cells -- turning them from tumor enablers into tumor opponents -- caused breast tumors in mice to shrink and withdraw from distant metastases.
Credit
Dana-Farber Cancer Institute
Usage Restrictions
None
License
Licensed content